{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T05:16:16Z","timestamp":1740460576012,"version":"3.37.3"},"reference-count":39,"publisher":"European Respiratory Society (ERS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2012,8,2]]},"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:p>Multidrug-resistant tuberculosis (TB) threatens TB control worldwide. The microscopic observation drug susceptibility (MODS) assay is a low-cost, high-performance TB diagnostic tool for rapid liquid culture and direct isoniazid and rifampicin drug susceptibility testing (DST). The objective of this study was to explore the potential for extending the MODS assay to rapid second-line DST and to identify critical concentrations of candidate drugs for prospective testing.<\/jats:p><jats:p>Sputum samples from 94 TB culture-positive patients receiving second-line TB agents were cultured following standardised MODS protocols, with a range of titrations of antimicrobial drugs added. Critical concentrations were determined using a modified Kaplan\u2013Meier survival curve analysis.<\/jats:p><jats:p>Candidate critical concentrations were determined for capreomycin (10 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), ciprofloxacin (1.25 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), cycloserine (40 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), ethambutol (10 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), ethionamide (5 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), kanamycin (5 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>), para-aminosalicylic acid (10 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>) and streptomycin (10 \u03bcg\u00b7mL<jats:sup>\u22121<\/jats:sup>). No cut-off point was identified for the other second-line drugs or for pyrazinamide.<\/jats:p><jats:p>At particular concentrations of some second-line TB drugs this novel Kaplan\u2013Meier analysis clearly differentiated populations that were susceptible or resistant. These candidate critical concentrations should now be tested in a range of epidemiological settings to define the performance of direct, second-line TB DST with MODS, offering potential low-cost second-line TB DST capacity.<\/jats:p>","DOI":"10.1183\/09031936.00059812","type":"journal-article","created":{"date-parts":[[2012,8,18]],"date-time":"2012-08-18T00:36:30Z","timestamp":1345250190000},"page":"1163-1171","source":"Crossref","is-referenced-by-count":14,"title":["Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay"],"prefix":"10.1183","volume":"41","author":[{"given":"Sean Patrick","family":"Fitzwater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Andrew","family":"Sechler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oswaldo","family":"Jave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Coronel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert H.","family":"Gilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jon S.","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"key":"2024102021172113000_41.5.1163.1","unstructured":"WHO Global Tuberculosis Control Report 2010. Geneva, World Health Organization, 2010."},{"key":"2024102021172113000_41.5.1163.2","unstructured":"Multidrug and Extensively Drug-resistant TB (M\/XDR-TB): 2010 Global Report on Surveillance and Response. Geneva, World Health Organization, 2010."},{"key":"2024102021172113000_41.5.1163.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69573-1"},{"key":"2024102021172113000_41.5.1163.4","doi-asserted-by":"publisher","DOI":"10.1086\/592991"},{"key":"2024102021172113000_41.5.1163.5","doi-asserted-by":"publisher","DOI":"10.1086\/521121"},{"key":"2024102021172113000_41.5.1163.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.319.5865.894"},{"key":"2024102021172113000_41.5.1163.7","doi-asserted-by":"publisher","DOI":"10.3201\/eid1303.061400"},{"key":"2024102021172113000_41.5.1163.8","unstructured":"Strategic and Technical Advisory Group for Tuberculosis: Report on Conclusions and Recommendations. Seventh Meeting. Geneva, World Health Organization, 2007."},{"key":"2024102021172113000_41.5.1163.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068273"},{"key":"2024102021172113000_41.5.1163.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055524"},{"key":"2024102021172113000_41.5.1163.11","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4432-4437.2004"},{"key":"2024102021172113000_41.5.1163.12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.3976-3979.2002"},{"key":"2024102021172113000_41.5.1163.13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10096-002-0855-5","article-title":"Use of receiver operating characteristic curves to assess the performance of a microdilution assay for determination of drug susceptibility of clinical isolates of Mycobacterium tuberculosis","volume":"22","author":"Luna-Herrera","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024102021172113000_41.5.1163.14","first-page":"845","article-title":"The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis","volume":"18","author":"Brady","year":"2008","journal-title":"J Vis Exp"},{"key":"2024102021172113000_41.5.1163.15","unstructured":"Laboratory Servicesin in TB control. Parts I, II, and III. WHO\/tb\/98.258. Geneva, World Health Organization, 1998."},{"key":"2024102021172113000_41.5.1163.16","first-page":"775","article-title":"Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria","volume":"87","author":"Kubica","year":"1963","journal-title":"Am Rev Respir Dis"},{"key":"2024102021172113000_41.5.1163.17","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","article-title":"Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media","volume":"37","author":"Pfyffer","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2024102021172113000_41.5.1163.18","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1934-1936.2001"},{"key":"2024102021172113000_41.5.1163.19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3616-3619.2003"},{"key":"2024102021172113000_41.5.1163.20","first-page":"1241","article-title":"In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand","volume":"84","author":"Pracharktam","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"2024102021172113000_41.5.1163.21","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.688-692.2006"},{"key":"2024102021172113000_41.5.1163.22","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.811-818.2006"},{"key":"2024102021172113000_41.5.1163.23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.5.1873-1874.2002"},{"key":"2024102021172113000_41.5.1163.24","first-page":"142","article-title":"Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems","volume":"32","author":"Huang","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"2024102021172113000_41.5.1163.25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/JCM.38.3.1203-1208.2000","article-title":"Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru","volume":"38","author":"Caviedes","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2024102021172113000_41.5.1163.26","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.12.4750-4752.2002"},{"key":"2024102021172113000_41.5.1163.27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/jcm.34.2.324-328.1996","article-title":"Multiprimer PCR system for differential identification of mycobacteria in clinical samples","volume":"34","author":"Del Portillo","year":"1996","journal-title":"J Clin Microbiol"},{"key":"2024102021172113000_41.5.1163.28","first-page":"21","article-title":"Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes","volume":"41","author":"Canetti","year":"1969","journal-title":"Bull World Health Organ"},{"key":"2024102021172113000_41.5.1163.29","first-page":"565","article-title":"Mycobacteria: laboratory methods for testing drug sensitivity and resistance","volume":"29","author":"Canetti","year":"1963","journal-title":"Bull World Health Organ"},{"key":"2024102021172113000_41.5.1163.30","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.3.1235-1239.2003"},{"key":"2024102021172113000_41.5.1163.31","doi-asserted-by":"publisher","DOI":"10.1159\/000093035"},{"key":"2024102021172113000_41.5.1163.32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/jcm.22.6.919-923.1985","article-title":"Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods","volume":"22","author":"Siddiqi","year":"1985","journal-title":"J Clin Microbiol"},{"key":"2024102021172113000_41.5.1163.33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/jcm.18.3.689-696.1983","article-title":"Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens","volume":"18","author":"Roberts","year":"1983","journal-title":"J Clin Microbiol"},{"key":"2024102021172113000_41.5.1163.34","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1128\/jcm.35.12.3325-3327.1997","article-title":"Reliability of mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to ethambutol and streptomycin","volume":"35","author":"Bergmann","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2024102021172113000_41.5.1163.35","doi-asserted-by":"publisher","DOI":"10.2741\/1290"},{"key":"2024102021172113000_41.5.1163.36","first-page":"748","article-title":"Activation of pyrazinamide and nicotinamide in acidic environments in vitro","volume":"70","author":"McDermott","year":"1954","journal-title":"Am Rev Tuberc"},{"key":"2024102021172113000_41.5.1163.37","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/AAC.24.4.600","article-title":"Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity","volume":"24","author":"Butler","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102021172113000_41.5.1163.38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.7.1002"},{"key":"2024102021172113000_41.5.1163.39","first-page":"282","article-title":"Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance","volume":"14","author":"Kam","year":"2010","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/09031936.00059812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T06:39:01Z","timestamp":1740379141000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/09031936.00059812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":39,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,4,30]]},"published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1183\/09031936.00059812"],"URL":"https:\/\/doi.org\/10.1183\/09031936.00059812","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2012,8,16]]}}}